Brian McKelligon
President and CEO, Director at Akoya Biosciences, Inc. (AKYA) since April 2021
Brian McKelligon has filed 22 insider reports with the SEC since April 2021, as president and CEO and director at Akoya Biosciences, Inc. (AKYA). Brian McKelligon made no open-market purchases or sales in the last 12 months. The latest filing, on July 11, 2025, reports shares withheld for taxes or exercise price and other acquisition or disposition at Akoya Biosciences, Inc. (AKYA).
- Filings
- 22
- Companies
- 1
- Bought on market
- None
- Sold on market
- $458K
Companies where Brian McKelligon is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| President and CEO, Directorsince April 2021 | 0 | $458K | Jul 11, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 8, 2025AKYAPresident and CEO Mckelligon Brian disposed of 947,688 shares, acquired 724,428 shares and covered exercise/tax liability with 196,866 shares, closing all direct ownership in the companyForm 4Shares withheld for taxes or exercise priceOther acquisition or disposition
- Mar 23, 2025AKYAPresident and CEO Mckelligon Brian covered exercise/tax liability with 7,550 shares, decreasing direct ownership by 2% to 420,126 unitsForm 4Shares withheld for taxes or exercise price
- Mar 1, 2025AKYAPresident and CEO Mckelligon Brian covered exercise/tax liability with 15,807 shares, decreasing direct ownership by 4% to 427,676 unitsForm 4Shares withheld for taxes or exercise price
- Nov 19, 2024AKYAPresident and CEO Mckelligon Brian was granted 218,750 shares, increasing direct ownership by 97% to 443,483 unitsForm 4Grant or award
- Jun 11, 2024-$15.6KAKYAPresident and CEO Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $15,630 worth of shares (7,500 units at $2.08)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 6, 2024-$15.1KAKYAMckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $15,064 worth of shares (7,500 units at $2.01)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 23, 2024AKYAMckelligon Brian covered exercise/tax liability with 7,135 shares, decreasing direct ownership by 3% to 224,733 unitsForm 4Shares withheld for taxes or exercise price
- Mar 20, 2024-$37.2KAKYAMckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $37,243 worth of shares (7,500 units at $4.97)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 13, 2024-$37KAKYAMckelligon Brian sold $37,042 worth of shares (7,500 units at $4.94) and exercised 7,500 shares at a strike of $0.30 (Amendment)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 13, 2024-$37KAKYAMckelligon Brian sold $37,035 worth of shares (7,500 units at $4.94), decreasing direct ownership by 3% to 224,368 unitsForm 4Open-market sale10b5-1 plan
- Mar 1, 2024AKYAMckelligon Brian was granted 87,500 shares and covered exercise/tax liability with 8,195 shares, increasing direct ownership by 52% to 231,868 units (Amendment)Form 4Grant or awardShares withheld for taxes or exercise price
- Mar 1, 2024AKYAMckelligon Brian was granted 87,500 shares and covered exercise/tax liability with 10,244 shares, decreasing direct ownership by 32% to 103,506 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Dec 19, 2023-$33.6KAKYAMckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $33,566 worth of shares (7,500 units at $4.48)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 12, 2023-$31.9KAKYAMckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $31,871 worth of shares (7,500 units at $4.25)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 6, 2023-$28.5KAKYASEC Form 4 filed by Mckelligon BrianForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 23, 2023AKYASEC Form 4 filed by Mckelligon BrianForm 4Shares withheld for taxes or exercise price
- Mar 14, 2023-$45.9KAKYASEC Form 4: Mckelligon Brian exercised 5,000 shares at a strike of $0.30 and sold $45,852 worth of shares (5,000 units at $9.17) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 6, 2022-$60.4KAKYASEC Form 4: Mckelligon Brian exercised 5,000 shares at a strike of $0.30 and sold $60,415 worth of shares (5,000 units at $12.08) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 7, 2022-$64.2KAKYASEC Form 4: Mckelligon Brian exercised 5,000 shares at a strike of $0.30 and sold $64,170 worth of shares (5,000 units at $12.83) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 15, 2022-$51.3KAKYASEC Form 4: Mckelligon Brian exercised 5,000 shares at a strike of $0.30 and sold $51,260 worth of shares (5,000 units at $10.25)Form 4Exercise or conversion of a derivativeOpen-market sale
- Mar 23, 2022AKYASEC Form 4: Mckelligon Brian was granted 80,000 sharesForm 4Grant or award
- Apr 20, 2021AKYASEC Form 3: McKelligon Brian claimed no ownership of No securities are beneficially owned.Form 3New insider
Compare Brian McKelligon with
- Brian McKelligon vs Scott Mendel1 shared
- Brian McKelligon vs Niro Ph.D Ramachandran1 shared
- Brian McKelligon vs Jennifer Kamocsay1 shared
- Brian McKelligon vs John Frederick Ek1 shared
- Brian McKelligon vs Pascal Bamford1 shared
- Brian McKelligon vs Matthew Winkler1 shared
Other insiders at the same companies
- Scott MendelAKYA
- Niro Ph.D RamachandranAKYA
- Jennifer KamocsayAKYA
- John Frederick EkAKYA
- Pascal BamfordAKYA
- Matthew WinklerAKYA
- Robert G SheplerAKYA
- Thomas P SchnettlerAKYA
- Thomas A. RaffinAKYA
- Goldman Myla LaiAKYA
Questions about Brian McKelligon
- What is Brian McKelligon's role at Akoya Biosciences, Inc.?
- Brian McKelligon reports to the SEC as president and CEO and director at Akoya Biosciences, Inc. (AKYA), according to the latest filing on July 11, 2025.
- Has Brian McKelligon bought or sold stock recently?
- The most recent open-market sale was on June 11, 2024: sold 7,500 shares of Akoya Biosciences, Inc. (AKYA) for $15.6K at an average of $2.08.
- How do I get alerts when Brian McKelligon files?
- Follow Brian McKelligon on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Brian McKelligon (SEC CIK 0001857447). Totals count each trade once, skipping amendments whose original is on file, from Apr 20, 2021 on. View on SEC EDGAR · Get this as JSON